Acne Warrior Clearing Astringent

Description

Acne Warrior Clearing Astringent is a topical formulation designed for the management of acne. The product is presented in a package label format, with the principal display panel providing essential information regarding its use and application. The effective date of this labeling is February 9, 2023. For visual reference, an image of the Acne Warrior Clearing Astringent label is available.

Uses and Indications

This drug is indicated for the treatment of skin irritation and dryness associated with topical acne medications. It is recommended that only one topical acne medication be used at a time to minimize the risk of irritation.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. Initially, it is advised to start with one application daily. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once a day or every other day. For patients who are new to the product, it is important to apply it sparingly to one or two small affected areas during the first three days of use. If no discomfort is experienced during this initial period, the patient may then proceed to follow the previously mentioned application guidelines.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

This product is intended for external use only. It is flammable; therefore, it must be kept away from fire or flame. When utilizing this product, healthcare professionals should advise patients that the likelihood of skin irritation and dryness may increase if another topical acne medication is used concurrently. In the event of irritation, it is recommended that only one topical acne medication be employed at a time to mitigate adverse effects.

In case of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire or flame.

In clinical use, skin irritation and dryness are common adverse reactions associated with this product. The likelihood of these reactions increases when the product is used concurrently with other topical acne medications. Therefore, if patients experience irritation, it is recommended that they limit their use to one topical acne medication at a time to mitigate these effects.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical agents and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Warrior Clearing Astringent (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Acne Warrior Clearing Astringent in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, which may include teratogenic effects. Given these concerns, pregnant women are advised to consult a healthcare provider before using this product to discuss potential risks and alternative options.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children. It is crucial to emphasize that if the medication is swallowed, patients must seek medical help or contact a Poison Control Center immediately. This information is vital for ensuring the safety of children and preventing potential harm.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness. Care should be taken to keep the product away from fire or flame to prevent any hazards. Additionally, it is crucial to keep the product out of reach of children to ensure safety. Once opened, the product should be discarded to avoid any potential risks associated with prolonged exposure.

Additional Clinical Information

The route of administration for the medication is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Acne Warrior Clearing Astringent, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)